197 related articles for article (PubMed ID: 1683154)
1. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
3. X-linked lymphoproliferative syndrome.
Sullivan JL; Woda BA
Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
Tatsumi E; Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
[TBL] [Abstract][Full Text] [Related]
6. [X-chromosomal recessively inherited lymphoproliferative syndrome. An analysis of EBV-induced immune deficiency].
Kammermeier-Schmidt U; Weiss M; Belohradsky BH
Monatsschr Kinderheilkd; 1993 Mar; 141(3):201-6. PubMed ID: 8386321
[TBL] [Abstract][Full Text] [Related]
7. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
Schuster V; Dohrmann E; Kreth HW
Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
[TBL] [Abstract][Full Text] [Related]
9. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
Purtilo DT
Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
[TBL] [Abstract][Full Text] [Related]
10. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
Loeffel S; Chang CH; Heyn R; Harada S; Lipscomb H; Sinangil F; Volsky DJ; McClain K; Ochs H; Purtilo DT
Arch Pathol Lab Med; 1985 Jun; 109(6):546-50. PubMed ID: 2986573
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
Purtilo DT
Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].
Grosieux C; Amoric JC; Mechinaud F; Moreau A; Mussini JM; Fesneau H; Dreno B; Bureau B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1996; 123(6-7):387-92. PubMed ID: 8959062
[TBL] [Abstract][Full Text] [Related]
13. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects.
Harada S; Sakamoto K; Seeley JK; Lindsten T; Bechtold T; Yetz J; Rogers G; Pearson G; Purtilo DT
J Immunol; 1982 Dec; 129(6):2532-5. PubMed ID: 6292290
[TBL] [Abstract][Full Text] [Related]
14. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
[TBL] [Abstract][Full Text] [Related]
15. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
16. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus.
Lanyi A; Li B; Li S; Talmadge CB; Brichacek B; Davis JR; Kozel BA; Trask B; van den Engh G; Uzvolgyi E; Stanbridge EJ; Nelson DL; Chinault C; Heslop H; Gross TG; Seemayer TA; Klein G; Purtilo DT; Sumegi J
Genomics; 1997 Jan; 39(1):55-65. PubMed ID: 9027486
[TBL] [Abstract][Full Text] [Related]
17. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.
Rousset F; Souillet G; Roncarolo MG; Lamelin JP
Clin Exp Immunol; 1986 Feb; 63(2):280-9. PubMed ID: 3009061
[TBL] [Abstract][Full Text] [Related]
18. Immunopathology of the X-linked lymphoproliferative syndrome.
Purtilo DT
Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
[TBL] [Abstract][Full Text] [Related]
19. Immunodeficiency as a factor in lymphomagenesis.
Purtilo DT; Sakamoto K
Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
[TBL] [Abstract][Full Text] [Related]
20. [X chromosome-linked lymphoproliferative syndrome (Duncan's disease)].
Král V; Jílek D; Pajerek J; Stasný J; Kofer J; Vávra M; Richter J
Cas Lek Cesk; 1990 Feb; 129(8):247-51. PubMed ID: 2158858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
